| Literature DB >> 30046949 |
Yoshimi Iwasaki1, Mitsuru Ishizuka2, Kazutoshi Takagi2, Hiroyuki Hachiya2, Norisuke Shibuya2, Yusuke Nishi2, Taku Aoki2, Keiichi Kubota2.
Abstract
BACKGROUND: Although the use of laparoscopic resection for colon cancer (LRC) has been increasing, conversion to open surgery sometimes becomes necessary because of intraoperative difficulties. Although the Glasgow prognostic score (GPS) is well known to be a predictor of outcome in patients with various cancers, it is unclear whether the preoperative GPS can predict the need for conversion from laparoscopic to open surgery.Entities:
Keywords: Colon cancer; Conversion; Glasgow prognostic score; Laparoscopic surgery; Risk factor
Mesh:
Substances:
Year: 2018 PMID: 30046949 PMCID: PMC6430750 DOI: 10.1007/s00464-018-6369-8
Source DB: PubMed Journal: Surg Endosc ISSN: 0930-2794 Impact factor: 4.584
Characteristics of patients who underwent laparoscopic resection for colon cancer with or without conversion
| Variables | Conversion (+) | Conversion (−) |
|
|---|---|---|---|
| Age (years) | 69 (41–89) | 67 (31–100) | 0.537 |
| Gender | |||
| Male | 17 (60.7) | 155 (55.4) | |
| Female | 11 (39.3) | 125 (44.6) | 0.586 |
| BMI (kg/m2) | 22.8 (16.3–32.6) | 22.2 (13.3–37.6) | 0.766 |
| ASA grade | |||
| 1 | 6 (21.4) | 55 (19.6) | |
| 2 | 20 (71.5) | 205 (73.2) | |
| 3 | 2 (7.1) | 20 (7.2) | 0.974 |
| Cardiopulmonary disease | |||
| Absence | 23 (82.1) | 228 (81.4) | |
| Presence | 5 (17.9) | 52 (18.6) | 0.926 |
| Previous laparotomy | |||
| Absence | 18 (64.2) | 196 (69.8) | |
| Presence | 10 (35.7) | 84 (30.2) | 0.531 |
| Preoperative ileus | |||
| Absence | 21 (75.0) | 270 (96.4) | |
| Presence | 7 (25.0) | 10 (3.6) | < 0.001 |
| CEA (ng/l) | 3.7 (1–1450) | 2.9 (1–3330) | 0.439 |
| CA19-9 (U/mL) | 6 (2-396) | 8 (2–12000) | 0.648 |
| Hgb (g/dL) | 12.6 (7.6–16.9) | 12.7 (4.9–17.1) | 0.726 |
| GPS | |||
| 0 | 16 (57.2) | 218 (77.9) | |
| 1 | 6 (21.4) | 46 (16.4) | |
| 2 | 6 (21.4) | 16 (5.7) | 0.005 |
| Tumor location | |||
| Right-sided colon | 12 (42.9) | 126 (45.0) | |
| Left-sided colon | 16 (57.1) | 154 (55.0) | 0.828 |
| Tumor size (mm) | 38 (2–80) | 37 (5–120) | 0.418 |
| Very large tumor (> 7 cm) | |||
| Absence | 22 (78.6) | 257 (91.8) | |
| Presence | 6 (21.4) | 23 (8.2) | 0.022 |
| pTNM stage | |||
| 0 | 2 (7.1) | 18 (6.4) | |
| I | 5 (17.9) | 83 (29.6) | |
| II | 4 (14.3) | 78 (27.9) | |
| III | 13 (46.4) | 80 (28.6) | |
| IV | 4 (14.3) | 21 (7.5) | 0.128 |
| Pathology | |||
| Well | 13 (46.4) | 103 (36.8) | |
| Moderately | 12 (42.9) | 164 (58.5) | |
| Poorly | 2 (7.1) | 5 (1.8) | |
| Mucinous | 1 (3.6) | 8 (2.9) | 0.173 |
Categorical variables were expressed as number (percent) and compared using Chi-Square test. Continuous variables were expressed as median (range) and compared using Mann–Whitney test
ASA American Society of Anesthesiologists, BMI body mass index, CA19-9 carbohydrate antigen 19-9, CEA carcinoembryonic antigen, GPS Glasgow prognostic score, pTNM pathologic tumor, nodes, metastases
Relationships between clinical characteristics and GPS
| Variables | GPS 0 or 1 | GPS2 |
|
|---|---|---|---|
| Age (years) | 67 (31–100) | 74 (48–87) | 0.065 |
| Gender | |||
| Male | 161 (56.3) | 11 (50.0) | |
| Female | 125 (43.7) | 11 (50.0) | 0.567 |
| BMI (kg/m2) | 22.4 (13.3–37.6) | 20.6 (15.9–30.7) | 0.011 |
| ASA grade | |||
| 1 | 59 (20.6) | 2 (9.1) | |
| 2 | 209 (73.1) | 16 (72.7) | |
| 3 | 18 (6.3) | 4 (18.2) | 0.067 |
| Cardiopulmonary disease | |||
| Absence | 236 (82.5) | 15 (68.2) | |
| Presence | 50 (17.5) | 7 (31.8) | 0.095 |
| Previous laparotomy | |||
| Absence | 199 (69.6) | 15 (68.2) | |
| Presence | 87 (30.4) | 7 (31.8) | 0.891 |
| Preoperative ileus | |||
| Absence | 271 (94.8) | 20 (90.9) | |
| Presence | 15 (5.2) | 2 (9.1) | 0.447 |
| CEA (ng/l) | 2.9 (1.0–294) | 6.2 (1.3–3330) | 0.007 |
| CA19-9 (U/mL) | 7 (2–12000) | 9 (2–1410) | 0.234 |
| Hgb (g/dL) | 12.9 (4.9–17.1) | 11.3 (7.4–13.8) | < 0.001 |
| Tumor location | |||
| Right-sided colon | 126 (44.1) | 12 (54.5) | |
| Left-sided colon | 160 (55.9) | 10 (45.5) | 0.34 |
| Tumor size (mm) | 35 (2–120) | 51 (22–105) | 0.001 |
| Very large tumor (> 7 cm) | |||
| Absence | 265 (92.7) | 14 (63.6) | < 0.001 |
| Presence | 21 (7.3) | 8 (36.4) | |
| pTNM stage | |||
| 0 | 19 (6.6) | 1 (4.5) | < 0.001 |
| I | 87 (30.4) | 1 (4.5) | |
| II | 74 (25.9) | 8 (36.4) | |
| III | 88 (30.8) | 5 (22.8) | |
| IV | 18 (6.3) | 7 (31.8) | |
| Pathology | |||
| Well | 109 (38.1) | 7 (31.9) | 0.805 |
| Moderately | 163 (57.0) | 13 (59.1) | |
| Poorly | 6 (2.1) | 1 (4.5) | |
| Mucinous | 8 (2.8) | 1 (4.5) | |
Categorical variables were expressed as number (percent) and compared using Chi-Square test. Continuous variables were expressed as median (range) and compared using Mann–Whitney test
ASA American Society of Anesthesiologists, BMI body mass index, CA19-9 carbohydrate antigen 19-9, CEA carcinoembryonic antigen, GPS Glasgow prognostic score, pTNM pathologic tumor, nodes, metastases
Univariate and multivariate analyses in relation to conversion to open surgery
| Variables | Univariate analyses | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| Odds ratio | 95% CI | Odds ratio | 95% CI | |||
| Age (≥ 65/< 65) | 0.467 | 1.350 | 0.601–3.030 | |||
| Gender (female/male) | 0.587 | 0.802 | 0.363–1.775 | |||
| BMI (> 25/≤ 25) | 0.254 | 1.632 | 0.703–3.784 | |||
| ASA (III/I, II) | 1.000 | 1.000 | 0.221–4.520 | |||
| Cardiopulmonary disease (presence/absence) | 0.926 | 0.953 | 0.346–2.625 | |||
| Previous laparotomy (presence/absence) | 0.532 | 1.296 | 0.574–2.926 | |||
| Preoperative ileus (presence/absence) | < | 9.000 | 3.109–26.06 |
| 7.405 | 2.386–22.98 |
| CEA (> 5.0/≤ 5.0 ng/mL) | 0.480 | 1.341 | 0.594–3.030 | |||
| CA19-9 (> 37/≤ 37 U/mL) | 0.855 | 1.124 | 0.318–3.970 | |||
| Hgb (< 10/≥ 10 g/dL) | 0.689 | 1.232 | 0.444–3.420 | |||
| GPS (2/0, 1) |
| 4.500 | 1.600–12.66 |
| 3.352 | 1.049–10.71 |
| Very large tumor (> 7/≤ 7 cm) |
| 3.047 | 1.123–8.271 | 0.193 | 2.144 | 0.680–6.766 |
| Tumor location (left/right) | 0.828 | 1.091 | 0.498–2.391 | |||
| pTNM stage (III, IV/0, I, II) |
| 2.739 | 1.235–6.075 | 0.132 | 1.929 | 0.821–4.536 |
| Pathology (poorly, mucinous/well, moderately) | 0.181 | 2.465 | 0.658–9.232 | |||
Bold values indicate significance at P < 0.05
ASA American Society of Anesthesiologists, BMI body mass index, CA19-9 carbohydrate antigen 19-9, CI confidence interval, CEA carcinoembryonic antigen, GPS Glasgow prognostic score, pTNM pathologic tumor, nodes, metastases
Reasons for conversion to open surgery
| Reason | Number (%) |
|---|---|
| Adhesion | 9 (32) |
| Narrow operative space | 9 (32) |
| Direct invasion to adjacent organ | 7 (25) |
| Bleeding | 2 (7) |
| Intra-operative hypotension | 1 (4) |
| Total | 28 (100) |